Insider Transactions in Q4 2023 at Heron Therapeutics, Inc. (HRTX)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 17
2023
|
William P Forbes EVP, Chief Development Officer |
BUY
Open market or private purchase
|
Direct |
25,000
+24.04%
|
$25,000
$1.09 P/Share
|
|
Nov 16
2023
|
William P Forbes EVP, Chief Development Officer |
BUY
Open market or private purchase
|
Direct |
50,000
+48.08%
|
$0
$0.94 P/Share
|
|
Nov 16
2023
|
Ira Duarte EVP, Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
85,000
+50.0%
|
$0
$0.89 P/Share
|
|
Nov 16
2023
|
Craig A Collard Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
150,000
+44.58%
|
$0
$0.92 P/Share
|
|
Oct 13
2023
|
Lisa Peraza VP, Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
860
-1.54%
|
$0
$0.72 P/Share
|
|
Oct 13
2023
|
Lisa Peraza VP, Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,484
+2.18%
|
-
|